- Home
- XERS vs AIO Comparison
XERS vs AIO Comparison
Compare XERS & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- AIO
- Stock Information
- Founded
- XERS 2005
- AIO 2019
- Country
- XERS United States
- AIO United States
- Employees
- XERS N/A
- AIO N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- AIO Finance/Investors Services
- Sector
- XERS Health Care
- AIO Finance
- Exchange
- XERS Nasdaq
- AIO Nasdaq
- Market Cap
- XERS 752.7M
- AIO 808.3M
- IPO Year
- XERS 2018
- AIO N/A
- Fundamental
- Price
- XERS $5.11
- AIO $24.30
- Analyst Decision
- XERS Strong Buy
- AIO
- Analyst Count
- XERS 6
- AIO 0
- Target Price
- XERS $6.25
- AIO N/A
- AVG Volume (30 Days)
- XERS 2.0M
- AIO 141.5K
- Earning Date
- XERS 08-07-2025
- AIO 01-01-0001
- Dividend Yield
- XERS N/A
- AIO 9.05%
- EPS Growth
- XERS N/A
- AIO N/A
- EPS
- XERS N/A
- AIO N/A
- Revenue
- XERS $222,551,000.00
- AIO N/A
- Revenue This Year
- XERS $35.03
- AIO N/A
- Revenue Next Year
- XERS $18.31
- AIO N/A
- P/E Ratio
- XERS N/A
- AIO N/A
- Revenue Growth
- XERS 29.88
- AIO N/A
- 52 Week Low
- XERS $2.10
- AIO $15.09
- 52 Week High
- XERS $6.07
- AIO $20.25
- Technical
- Relative Strength Index (RSI)
- XERS 61.48
- AIO 55.54
- Support Level
- XERS $4.62
- AIO $24.38
- Resistance Level
- XERS $5.39
- AIO $24.78
- Average True Range (ATR)
- XERS 0.21
- AIO 0.33
- MACD
- XERS 0.07
- AIO -0.08
- Stochastic Oscillator
- XERS 71.72
- AIO 61.40
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.